Cowingene HPV 28 Genotyping Kit - Accurate HPV Detection by PCR | Taizhou Cowingene Biotech Co., Ltd.

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) is a cutting-edge molecular diagnostic tool designed to identify 28 high-risk human papillomavirus (HPV) subtypes with exceptional precision. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit leverages advanced PCR technology to provide rapid, reliable, and comprehensive HPV genotyping. For more information, visit the product page.

Key Features and Advantages

The Cowingene HPV 28 Genotyping Detection Kit stands out in the field of molecular diagnostics due to its innovative features and robust performance. Here are some of its core advantages:

• Comprehensive Genotyping: The kit detects 28 high-risk HPV subtypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83, and others, ensuring a broad coverage of clinically significant HPV strains.
• High Sensitivity and Specificity: Utilizing polymerase chain reaction (PCR) technology, the kit achieves exceptional detection accuracy, minimizing false positives and negatives.
• Flexible Sample Types: Validated for use with cervical swabs, urine, and self-collected vaginal samples, making it suitable for diverse clinical settings.
• Efficient Workflow: The liquid-based format simplifies processing, reducing the time and labor required for sample preparation.
• Regulatory Compliance: Developed in accordance with international standards, ensuring reliability and consistency across laboratories.

Technical Specifications

The Cowingene HPV 28 Genotyping Detection Kit is engineered to meet the highest standards of performance and usability. Below is a detailed overview of its technical parameters:

Parameter	Details
Validated Specimens	Cervical swab, Urine, Self-collected vaginal
Detected HPV Subtypes	8 tubes; 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Detection Method	PCR (Polymerase Chain Reaction)
Sensitivity	≥95% (based on clinical validation studies)
Specificity	≥98% (cross-reactivity testing confirmed)
Sample Preparation	Liquid-based, compatible with automated systems
Kit Components	8 tubes for multiplex detection, reagents, controls, and detailed protocols
Storage Conditions	-20°C for long-term storage; 4°C for short-term use

Application Scenarios

The Cowingene HPV 28 Genotyping Detection Kit is designed for use in a wide range of clinical and research settings. Its versatility and accuracy make it ideal for:

• Cervical Cancer Screening: Identifying high-risk HPV infections in women, enabling early intervention and reducing cancer mortality rates.
• Research and Development: Supporting studies on HPV epidemiology, vaccine efficacy, and disease progression.
• Public Health Programs: Facilitating large-scale screening initiatives in resource-limited settings due to its cost-effectiveness and ease of use.
• Diagnostic Laboratories: Enhancing workflow efficiency with its streamlined protocol and multiplex detection capabilities.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading innovator in molecular diagnostics, specializing in the development of advanced diagnostic solutions for infectious diseases. With a strong focus on research and development, the company has established itself as a trusted partner for healthcare providers, laboratories, and research institutions worldwide.

Founded on the principles of scientific excellence and customer-centric innovation, Taizhou Cowingene Biotech has consistently delivered products that meet the highest standards of quality and reliability. The company's commitment to improving global health is evident in its extensive portfolio of diagnostic kits, including the Cowingene HPV 28 Genotyping Detection Kit.

For more information about the company, visit the Taizhou Cowingene Biotech Co., Ltd. website.

Why Choose the Cowingene HPV 28 Genotyping Kit?

The Cowingene HPV 28 Genotyping Detection Kit offers several advantages that make it a preferred choice for healthcare professionals and researchers:

• Comprehensive Coverage: Detecting 28 high-risk HPV subtypes ensures a thorough assessment of infection risks.
• Scientific Backing: The kit is developed using the latest advancements in PCR technology, ensuring accuracy and reliability.
• Cost-Effective: The liquid-based format reduces reagent waste and labor costs, making it an economical choice for laboratories.
• User-Friendly: The intuitive protocol and clear results make it accessible for both experienced and novice users.

Authoritative Citations and References

The Cowingene HPV 28 Genotyping Detection Kit aligns with the standards set by the National Institute of Standards and Technology (NIST), which emphasizes the importance of precision and reliability in diagnostic technologies. According to NIST, "PCR technology is a gold standard in molecular diagnostics, providing a robust framework for detecting genetic material with high accuracy and reproducibility" (NIST, 2025).

For further information on NIST's role in advancing diagnostic standards, visit the NIST website.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit represents a significant advancement in HPV diagnostics, combining cutting-edge technology with user-friendly design. Its ability to detect 28 high-risk HPV subtypes with high sensitivity and specificity makes it an essential tool for cervical cancer screening, research, and public health initiatives. With the backing of Taizhou Cowingene Biotech Co., Ltd. and adherence to rigorous scientific standards, this kit is poised to make a meaningful impact on global health.

For more details, visit the Cowingene HPV 28 Genotyping Detection Kit product page.